Lofexidine Press Articles

National Institutes of Health: News and Events - NIDA NewsScan #58

Thursday 9th of September 2010 04:33:00 PM
Posted by admin / Under Lofexidine

January 14, 2009 --

continue reading »

Business Wire - US WorldMeds Completes Phase III Trial of Lofexidine for Treatment of Opiate Withdrawal Symptoms

Thursday 9th of September 2010 04:33:00 PM
Posted by admin / Under Lofexidine

June 16, 2008 -- Initial results show that opiate-dependent patients taking Lofexidine experience a significant reduction in withdrawal symptoms and stay in...

continue reading »

Deseret News (Salt Lake City) - Drug for opiate withdrawal will be tested in S.L.

Thursday 9th of September 2010 04:33:00 PM
Posted by admin / Under Lofexidine

October 16, 2006 -- The George E. Wahlen VA Medical Center in Salt Lake City is one of 14 clinical trial sites testing a non-addictive, non-narcotic treatment for...

continue reading »

Business Wire - US WorldMeds Initiates Phase III Trial of Lofexidine for Treatment of Opiate Withdrawal Symptoms

Thursday 9th of September 2010 04:33:00 PM
Posted by admin / Under Lofexidine

October 9, 2006 -- Lofexidine would be first non-addictive drug approved in the US to detoxify opiate addicts; has been used in an estimated 200,000 detoxifications...

continue reading »

Internal Medicine News - Detox drug affects QT interval

Thursday 9th of September 2010 04:33:00 PM
Posted by admin / Under Lofexidine

February 1, 2005 -- The alpha-2 agonist lofexidine, used with methadone for opioid detoxification, induced QT prolongation in a subject enrolled in a study of the...

continue reading »

Chain Drug Review - Non-opiate entry

Thursday 9th of September 2010 04:33:00 PM
Posted by admin / Under Lofexidine

December 15, 2003 -- Britannia Pharmaceuticals Ltd. has signed a licensing agreement with US World Meds LLC to further develop and launch lofexidine hydrochloride, a...

continue reading »